| # | Drug | Count |
|---|---|---|
| 0 | AMLODIPINE | 25 |
| 1 | LENALIDOMIDE | 22 |
| 2 | ASPIRIN | 19 |
| 3 | ASPIRIN 325 MG | 19 |
| 4 | ASPIRIN 81 MG | 19 |
| 5 | MAGNESIUM OXIDE | 19 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 18 |
| 7 | AMLODIPINE BESYLATE | 17 |
| 8 | SACUBITRIL AND VALSARTAN | 17 |
| 9 | FUROSEMIDE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VADADUSTAT | 2 | 0.0065 |
| 1 | OLOPATADINE HCL | 2 | 0.0055 |
| 2 | SELEGILINE HYDROCHLORIDE | 2 | 0.0034 |
| 3 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 1 | 0.0033 |
| 4 | CROTAMITON | 2 | 0.0033 |
| 5 | ACORAMIDIS HYDROCHLORIDE | 1 | 0.0027 |
| 6 | LAZERTINIB | 2 | 0.0023 |
| 7 | SOLIFENACIN SUCCIATE | 4 | 0.0021 |
| 8 | CARBIDOPA, LEVODOPA AND ENTACAPONE | 1 | 0.0021 |
| 9 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 1 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 5 | 0.0022 |
| 1 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 4 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 4 | 0.0008 |
| 6 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 3 | 0.0006 |
| 7 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 8 | Orexin Receptor Antagonist [EPC] | 9 | 0.0005 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |